GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Purchase Of Business

North China Pharmaceutical Co (SHSE:600812) Purchase Of Business : ¥0 Mil (TTM As of Jun. 2024)


View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Purchase Of Business?

North China Pharmaceutical Co's purchase of business for the three months ended in Jun. 2024 was ¥0 Mil. It means North China Pharmaceutical Co spent ¥0 Mil on purchasing business. North China Pharmaceutical Co's purchase of business for the trailing twelve months (TTM) ended in Jun. 2024 was ¥0 Mil.

Compared with last quarter (¥0 Mil in Mar. 2024 ), North China Pharmaceutical Co spent the same money on purchasing business in Jun. 2024 (¥0 Mil).

North China Pharmaceutical Co Purchase Of Business Historical Data

The historical data trend for North China Pharmaceutical Co's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co Purchase Of Business Chart

North China Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

North China Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

North China Pharmaceutical Co Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

North China Pharmaceutical Co Purchase Of Business Related Terms

Thank you for viewing the detailed overview of North China Pharmaceutical Co's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

North China Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Purchase Of Business
Comparable Companies
SZSE:300199 SZSE:000756 SHSE:600664 SZSE:002099 SHSE:600252 SHSE:600267 SZSE:000650 SHSE:600557 SHSE:601089 SZSE:300401 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XTAE:TEVA XSWX:SDZ NBIX NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015
Website
http://www.ncpc.com
North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
Executives
Gao Ren Long senior management
Lian Fa Zhe Director

North China Pharmaceutical Co Headlines

No Headlines